In this study, we demonstrate that the GluN2A-selective NMDA receptor blocker MPX-004 induces acute behavioral effects similar to those of ketamine, producing both antidepressant-like and schizophrenia-like effects. The gene discussed is GRIN2A; the disease is schizophrenia.